Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

2yrs ago Private Equity privateequitywire Views: 655

Ascenti Health acquired by bd-capital partners

Submitted 04/05/2021 - 1:52pm

Arrowpoint Advisory has advised Ascenti Health (Ascenti), a technology-led disruptor in the UK physiotherapy and mental wellbeing markets, on its sale to bd-capital partners (bd-capital). 

Ascenti started in 1996 as a small rehabilitation business helping victims of motor accidents recover from injury, and through organic growth and a series of acquisitions over the last 20 years has grown into the UK’s leading independent network of physical wellbeing services serving individuals, corporates, insurance companies, private medical insurers, and the UK government. Ascenti’s market-leading digital proposition is the only ‘end-to-end’ technology in the market. These systems, developed in-house by Ascenti, provide effective referral management, assessment and triage, practitioner allocation, booking engines, monitoring of outcomes and feedback to those paying for the services. 

bd-capital, established in 2019 by Richard Baker (former FTSE CEO and Chairman) and Andy Dawson (former Advent International Investment Partner), takes an operationally-led approach to its partnerships with businesses. bd-capital’s extensive operational expertise and experience will help accelerate Ascenti’s growth and development as the market leading digitally-led national network of physiotherapy and mental wellbeing services, helping improve the lives of thousands of people across the UK every day. 

Stephanie Dobrikova, CEO of Ascenti, says: “The Arrowpoint Advisory team are an absolute pleasure to work with. Their advice, guidance and industry insight has been excellent throughout and they worked incredibly hard to find us the right partners for the next stage in our exciting journey.” 

Bec Schultz, Investment Director of bd-capital, adds: “It has been a pleasure to work with the Arrowpoint Advisory team; their open and collaborative approach enabled a seamless and efficient process from kick-off to completion. Most importantly however, Arrowpoint understand that a transaction is often the first step in a long-term partnership between a seller and buyer – their ability to facilitate this relationship, as well as a successful transaction for both parties, sets them apart.” 

Karen Dawaf Harron, Director, Arrowpoint Advisory, concludes: “Ascenti is a pioneer in the physical wellbeing sector with a national network of clinics and practitioners and a market-leading digital proposition. The business has continued to adapt to the evolving needs of its clients and markets and is using technology to drive much-needed change and best practice. Stephanie and her team have built a unique platform and have an exciting future ahead. We were delighted to support them to find the right partner in bd-capital to take the business to the next stage. It was a real pleasure to work with the team and we will watch with interest as the business continues to go from strength to strength.” 

 

Like this article? Sign up to our free newsletter Author Profile Tags Deals & Transactions Acquisitions Healthcare & Life Sciences

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.